Cambridge, United Kingdom · Founded 2021 · Privately Held (backing)
Developer of transatlantic cancer immunotherapeutics designed to target a novel class of tumor-specific antigens. Epitopea is based in Cambridge, United Kingdom and was founded in 2021. It has raised $44.4 million.
Last price · $/share
—
Implied valuation
—
Total raised
$44.4M
Last round
—
Cap table — not yet on record
Epitopea's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Epitopea with a free account
·The complete investor list: 15 names
·Watch Epitopea: the Monday email on marks, rounds and moves
